Voriconazole for candidosis: an important addition?

被引：6

作者：

Graybill, JR ^{[1
]}

机构：

[1] Univ Texas, Hlth Sci Ctr, Div Infect Dis, San Antonio, TX 78229 USA

来源：

LANCET | 2005年 / 366卷 / 9495期

关键词：

D O I：

10.1016/S0140-6736(05)67579-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1413 / 1414

页数：2

共 9 条

[1] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[2] Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial [J].

Kullberg, BJ ;

Sobel, JD ;

Ruhnke, M ;

Pappas, PG ;

Viscoli, C ;

Rex, JH ;

Cleary, JD ;

Rubinstein, E ;

Church, LWP ;

Brown, JM ;

Schlamm, HT ;

Oborska, IT ;

Hilton, F ;

Hodges, MR .

LANCET, 2005, 366 (9495) :1435-1442

[3] Comparison of caspofungin and amphotericin B for invasive candidiasis. [J].

Mora-Duarte, J ;

Betts, R ;

Rotstein, C ;

Colombo, AL ;

Thompson-Moya, L ;

Smietana, J ;

Lupinacci, R ;

Sable, C ;

Kartsonis, N ;

Perfect, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2020-2029

[4] Guidelines for treatment of candidiasis [J].

Pappas, PG ;

Rex, JH ;

Sobel, JD ;

Filler, SG ;

Dismukes, WE ;

Walsh, TJ ;

Edwards, JE .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (02) :161-189

[5] Voriconazole treatment for less-common, emerging, or refractory fungal infections [J].

Perfect, JR ;

Marr, KA ;

Walsh, TJ ;

Greenberg, RN ;

DuPont, B ;

de la Torre-Cisneros, J ;

Just-Nübling, G ;

Schlamm, HT ;

Lutsar, I ;

Espinel-Ingroff, A ;

Johnson, E .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (09) :1122-1131

[6] Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole [J].

Pfaller, MA ;

Diekema, DJ ;

Boyken, L ;

Messer, SA ;

Tendolkar, S ;

Hollis, RJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (05) :1875-1880

[7]

REBOLI A, 2005, 45 INT C ANT AG CHEM

[8] A RANDOMIZED TRIAL COMPARING FLUCONAZOLE WITH AMPHOTERICIN-B FOR THE TREATMENT OF CANDIDEMIA IN PATIENTS WITHOUT NEUTROPENIA [J].

REX, JH ;

BENNETT, JE ;

SUGAR, AM ;

PAPPAS, PG ;

VANDERHORST, CM ;

EDWARDS, JE ;

WASHBURN, RG ;

SCHELD, WM ;

KARCHMER, AW ;

DINE, AP ;

LEVENSTEIN, MJ ;

WEBB, CD .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (20) :1325-1330

[9] Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. [J].

Walsh, TJ ;

Pappas, P ;

Winston, DJ ;

Lazarus, HM ;

Petersen, F ;

Raffalli, J ;

Yanovich, S ;

Stiff, P ;

Greenberg, R ;

Donowitz, G ;

Lee, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :225-234

← 1 →